DC Field | Value | Language |
---|---|---|
dc.contributor.author | J Joo | - |
dc.contributor.author | D Lee | - |
dc.contributor.author | Z Wu | - |
dc.contributor.author | J H Shin | - |
dc.contributor.author | H S Lee | - |
dc.contributor.author | Byoung-Mog Kwon | - |
dc.contributor.author | T L Huh | - |
dc.contributor.author | Y W Kim | - |
dc.contributor.author | S J Lee | - |
dc.contributor.author | T W Kim | - |
dc.contributor.author | T Lee | - |
dc.contributor.author | K H Liu | - |
dc.date.accessioned | 2017-04-19T09:39:36Z | - |
dc.date.available | 2017-04-19T09:39:36Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0142-2782 | - |
dc.identifier.uri | 10.1002/bdd.1837 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/11319 | - |
dc.description.abstract | Obovatol, a major constituent of the leaves of Magnolia obovata Thunb, is known to inhibit nuclear factor-κB activity and arachidonic acid-induced platelet aggregation. This study was performed to identify the metabolites of obovatol in human liver microsomes. Human liver microsomes incubated with obovatol in the presence of NADPH and/or UDPGA resulted in the formation of six metabolites, M1-M6. M1 and M2 were identified as hydroxyobovatol, on the basis of liquid chromatography/tandem mass spectrometric (LC-MS/MS) analysis. M1, M2 and obovatol were further metabolized to their glucuronide conjugates, obovatol-glucuronide (M3), obovatol-diglucuronide (M4) and hydroxyobovatol- glucuronide (M5 and M6). The inhibitory potency of obovatol on eight major human P450s was also investigated in human liver microsomes. In these experiments, obovatol strongly inhibited CYP2C19-mediated S-mephenytoin hydroxylase activity with an IC50 value of 0.8 μm, which could have implications for drug-drug interactions. | - |
dc.publisher | Wiley | - |
dc.title | In vitro metabolism of obovatol and its effect on cytochrome P450 enzyme activities in human liver microsomes = 오보바톨의 대사 물질 분석 및 안정성 | - |
dc.title.alternative | In vitro metabolism of obovatol and its effect on cytochrome P450 enzyme activities in human liver microsomes | - |
dc.type | Article | - |
dc.citation.title | Biopharmaceutics & Drug Disposition | - |
dc.citation.number | 4 | - |
dc.citation.endPage | 202 | - |
dc.citation.startPage | 195 | - |
dc.citation.volume | 34 | - |
dc.contributor.affiliatedAuthor | Byoung-Mog Kwon | - |
dc.contributor.alternativeName | 주정민 | - |
dc.contributor.alternativeName | 이두현 | - |
dc.contributor.alternativeName | Wu | - |
dc.contributor.alternativeName | 신정훈 | - |
dc.contributor.alternativeName | 이혜숙 | - |
dc.contributor.alternativeName | 권병목 | - |
dc.contributor.alternativeName | 허태린 | - |
dc.contributor.alternativeName | 김양원 | - |
dc.contributor.alternativeName | 이수준 | - |
dc.contributor.alternativeName | 김태완 | - |
dc.contributor.alternativeName | 이태호 | - |
dc.contributor.alternativeName | 이광현 | - |
dc.identifier.bibliographicCitation | Biopharmaceutics & Drug Disposition, vol. 34, no. 4, pp. 195-202 | - |
dc.identifier.doi | 10.1002/bdd.1837 | - |
dc.subject.keyword | drug interaction | - |
dc.subject.keyword | glucuronidation | - |
dc.subject.keyword | microsomes | - |
dc.subject.keyword | obovatol | - |
dc.subject.keyword | oxidation | - |
dc.subject.local | Drug interaction | - |
dc.subject.local | Drug interactions | - |
dc.subject.local | drug interaction | - |
dc.subject.local | drug interactions | - |
dc.subject.local | Glucuronidation | - |
dc.subject.local | glucuronidation | - |
dc.subject.local | microsomes | - |
dc.subject.local | Microsomes | - |
dc.subject.local | Obovatol | - |
dc.subject.local | obovatol | - |
dc.subject.local | Oxidation | - |
dc.subject.local | oxidation | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.